Neoadjuvant immunotherapy could considerably improve long-term outcomes and quality of life for patients with desmoplastic ...

Based in New Jersey (USA), to lead ORYZON’s CNS clinical development MADRID and CAMBRIDGE, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a ...

Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...

With rising electricity costs, frequent power outages, and increasing interest in renewable energy, homeowners are looking for smarter ways to manage their power consumption. One of the most effective ...

Bristol Myers Squibb (NYSE: BMY; BMS) beat analyst consensus forecasts by reporting higher than expected numbers for total revenue and its “growth” portfolio of drugs on which BMS is counting on for ...

Starday Records co-founder Harold "Pappy" Daily, who helped launch George Jones' career, would have turned 124 years old ...

On this week's #SundayGunday, we check out the Honcho, a handheld pump shotgun made by Charles Daly right here in the USA, ...

Four of the most reliable inline-six diesel engines are the Cummins 6BT, the Toyota 1HZ, the Mercedes-Benz OM606, and the BMW ...

Bristol-Myers Squibb is upgraded to Buy as its growth portfolio now offsets legacy declines, validating a bullish contrarian ...

The company projects 2026 revenues between $46.0bn and $47.5bn, with non-GAAP EPS ranging from $6.05 to $6.35.

Larry Bordeaux, 65, has been on blood thinners since 2010, after he started developing deadly clots following an operation.

AstraZeneca's full-year 2025 results are due on 10 February. Learn what investors should watch including Tagrisso sales, ...